GJIC
AGN

Gamble Jones Investment Counsel’s Allergan plc AGN Stock Holding History

Gamble Jones Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,939
Closed -$2.65M – 223
2017
Q3 		$2.65M Sell
12,939
-1,668
-11% -$388K 0.27% 75
2017
Q2 		$3.55M Sell
14,607
-323
-2% -$75.9K 0.37% 54
2017
Q1 		$3.57M Buy
14,930
+130
+0.9% +$30.3K 0.38% 50
2016
Q4 		$3.11M Buy
14,800
+3,695
+33% +$765K 0.34% 52
2016
Q3 		$2.56M Buy
11,105
+5,051
+83% +$1.23M 0.28% 69
2016
Q2 		$1.4M Buy
+6,054
New +$1.4M 0.15% 101
2015
Q2 		– Sell
-1,552
Closed -$462K – 227
2015
Q1 		$462K Buy
+1,552
New +$442K 0.05% 171

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Gamble Jones Investment Counsel's AGN Position: Q4 2017 in Review

Gamble Jones Investment Counsel sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 12,939 shares — an estimated $2.65M sold.

Gamble Jones Investment Counsel first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $3.57M in Q1 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Gamble Jones Investment Counsel reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Gamble Jones Investment Counsel sold 12,939 Allergan plc shares in Q4 2017, an estimated $2.65M.
  • Gamble Jones Investment Counsel first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Gamble Jones Investment Counsel's Allergan plc position peaked at $3.57M in Q1 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2017, filed 6 Feb 2018.